Clinical Trials Directory

Trials / Completed

CompletedNCT02904642

Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial

Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
537 (estimated)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.

Detailed description

Primary Objective The primary objective is to determine if text message reminders, with or without unconditionally provided incentives, can increase the proportion of children who receive measles vaccination by 15% at age ten months as compared to control arm children. Secondary Objectives 1. To conduct a secondary analysis of the primary outcome using survival analysis and time-to-immunization curves. 2. To determine if there is a differential effect on measles vaccine coverage based on mobile phone ownership and distance to the clinic. 3. To examine the effect of the interventions on measles coverage measured at twelve months of age. 4. To examine the completeness and costs of identifying children through a CHW approach versus the standard HDSS approach. 5. To evaluate the effect of the interventions on coverage of second dose of measles vaccine at 24 months. This secondary objective is contingent on receiving additional funding.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMS reminderCaregivers will receive two text message reminders for their child's measles immunization scheduled for 9 months of age
BEHAVIORALUnconditional IncentiveA mobile-money incentive in the amount of 150 Kenyan Shillings will be transferred to the enrolled caregiver's mobile phone when the child reaches nine months of age

Timeline

Start date
2016-12-06
Primary completion
2017-04-04
Completion
2017-04-04
First posted
2016-09-19
Last updated
2018-03-01

Source: ClinicalTrials.gov record NCT02904642. Inclusion in this directory is not an endorsement.

Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial (NCT02904642) · Clinical Trials Directory